Beijing Disability Risk and Ageing Monitoring Study
Launched by XUANWU HOSPITAL, BEIJING · Apr 28, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Beijing Disability Risk and Ageing Monitoring Study is a research project that started in 2023 to help understand and improve the health of older adults living in Beijing, China. The goal of this study is to create tools that can help predict the risk of disabilities and other health issues in seniors. This will allow for early intervention and better support for older individuals as they age.
To participate in this study, you need to be at least 60 years old and have lived in the community for over a year. You'll also need to sign a consent form agreeing to take part. If you join, you'll be asked to complete a survey about your health and daily activities. This information will help researchers develop standards to assess disability risks in older adults, ultimately aiming to enhance their quality of life. The study is currently looking for participants, so if you or someone you know fits the criteria, it could be a great opportunity to contribute to important health research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 60 years or older
- • Lived in the community for more than 1 year
- • Signed the informed consent form
- Exclusion Criteria:
- • Cannot complete the survey
About Xuanwu Hospital, Beijing
Xuanwu Hospital, located in Beijing, is a leading clinical research institution renowned for its commitment to advancing medical knowledge and improving patient care. Affiliated with Capital Medical University, the hospital specializes in neurology and rehabilitation, providing a robust framework for innovative clinical trials. With a multidisciplinary team of experienced researchers and healthcare professionals, Xuanwu Hospital focuses on conducting high-quality, ethically sound studies that aim to explore new treatment modalities and enhance therapeutic outcomes. Through its dedication to research excellence and patient-centered approaches, Xuanwu Hospital plays a pivotal role in the advancement of healthcare solutions both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Yi Tang, MD., PhD
Principal Investigator
Xuanwu Hospital, Beijing
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported